Editorial
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Oncol. Jul 24, 2024; 15(7): 786-789
Published online Jul 24, 2024. doi: 10.5306/wjco.v15.i7.786
Anaplastic thyroid cancer: Unveiling advances in diagnosis and management
Treshita Dey, Budhi Singh Yadav
Treshita Dey, Budhi Singh Yadav, Department of Radiotherapy & Oncology, Post- Graduate Institute of Medical Education & Research, Chandigarh 160012, India
Author contributions: Yadav BS and Dey T contributed to conceptualization, literature review, manuscript writing, editing, and final approval.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: Https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Budhi Singh Yadav, MD, Professor, Department of Radiotherapy & Oncology, Post-Graduate Institute of Medical Education & Research, Sector 12, Chandigarh 160012, India. drbudhi@gmail.com
Received: December 29, 2023
Revised: May 22, 2024
Accepted: June 11, 2024
Published online: July 24, 2024
Processing time: 199 Days and 12.8 Hours
Core Tip

Core Tip: Anaplastic thyroid cancer is an aggressive disease. Surgery is the main treatment. Combination of radiotherapy and chemotherapy help to further improve the outcome of patients with this malignancy. Immunotherapy, targeted therapies, and molecular insights herald a new dawn for a patient cohort hitherto consigned to bleak prognoses.